Medical Device Partnership
Secured strategic partnership with ni2o for brain-computer interface applications, enabling real-time neural signal processing with 27x compute efficiency.
Type 1 Compute (T1C) is building neuromorphic processors that run AI directly on-device, eliminating dependence on the cloud. Our chips deliver GPU-level compute at just 1W with sub-100ms latency, enabling real-time learning, adaptation, and decision-making at the edge. From medical devices that must continuously adapt to patients to robots that learn new tasks in the field, T1C makes possible what traditional, cloud-bound architectures never could.
Secured strategic partnership with ni2o for brain-computer interface applications, enabling real-time neural signal processing with 27x compute efficiency.
Successfully deployed neuromorphic model predictive control system for building automation, demonstrating significant energy savings in real-time HVAC optimization.
Completed angel funding round to accelerate development of brain-inspired computing solutions for industrial applications.
Filed 5 provisional patents covering brain-inspired computing architectures for Physical AI applications including NeuroVM and sensor fusion acceleration.
Demonstrated 347x energy efficiency improvement over traditional CPUs using Intel Loihi-2 neuromorphic chip for autonomous driving sensor fusion.
If you are interested in joining, please get in touch
We are grateful for the support of Dr. Newton Howard, Antler VC, and the NVIDIA Inception Program.